Rtw Investments, LP Immunocore Holdings PLC Transaction History
Rtw Investments, LP
- $6.27 Billion
- Q3 2024
A detailed history of Rtw Investments, LP transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Rtw Investments, LP holds 4,869,798 shares of IMCR stock, worth $158 Million. This represents 2.42% of its overall portfolio holdings.
Number of Shares
4,869,798
Previous 4,869,798
-0.0%
Holding current value
$158 Million
Previous $165 Million
8.14%
% of portfolio
2.42%
Previous 2.76%
Shares
10 transactions
Others Institutions Holding IMCR
# of Institutions
141Shares Held
41.4MCall Options Held
197KPut Options Held
451K-
Wellington Management Group LLP Boston, MA7.05MShares$229 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.5MShares$211 Million0.12% of portfolio
-
Primecap Management CO Pasadena, CA2.47MShares$80.1 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.16MShares$70 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY1.52MShares$49.1 Million0.51% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.42B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...